Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from
FinraMoving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.
Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.
Summary:
- Volatility is at a recent 2 week high. A high volatility of stock movement indicates uncertainty.
- MACD is crossing MACD signal line at 1.0. MACD crossing signal line is bullish signal.
| MarketCap | 221.7B |
|---|---|
| PE Ratio | 35.1 |
| PEG Ratio | 2.2 |
| P/B | 6.0 |
| P/S (ttm) | 5.2 |
| Earning Growth (QoQ) | 218% |
| Revenue Growth (QoQ) | |
| Short % | 1% |
| Held by Institutions % | 76% |
| 1 Day Vol Adjusted Return | 1.0 |
| 1 Month Vol Adjusted Return | 0.2 |
| 3 Month Vol Adjusted Return | 3.5 |
| 6 Month Vol Adjusted Return | 1.4 |
| 20 Days SMA Price ZScore | 2.4 |
| 50 Days SMA Price ZScore | 0.4 |
| 12 -26 Days PPO | -0.5 |
| 1 Month Average Short Volume Ratio | 27.7 |
| 1 Day Volume Change ZScore | -0.7 |
| 1 Month Daily Vol | 1.4 |
Stock news
In this article, we will take a look at the 10 stocks making moves on financial results. You can skip our detailed analysis of these companies, and go directly to the 5 Stocks Making Moves on Financial Results. Investors are closely watching the third-quarter earnings season, with several big-cap companies releasing their financial results. Tesla, […]
Abbott Laboratories (NYSE: ABT) has given investors plenty to like through the years. Abbott provided its third-quarter update before the market opened on Wednesday. Here are three things that investors should love about the healthcare-giant's Q3 results.
Abbott Laboratories (ABT), a multinational medical devices and health care company, reported better-than-expected third-quarter results driven by solid COVID-19 related sales, new product approvals, and overall strong demand for all of its offerings. Following the news, shares jumped 3.3% to close at $123.31 on October 20. The company reported adjusted earnings of $1.40 per share, up 42.9% year-over-year, beating consensus estimates of $0.93 per share. Additionally, quarterly sales stood at $10.
The S&P 500 and the Dow climbed on Wednesday with the Dow hitting an intraday record high as investors eyed better than expected third-quarter earnings from U.S. companies. While the Nasdaq lagged as technology stocks took a breather, the Dow Jones Industrials Average surpassed its previous record reached in mid-August before paring gains during the session.
Abbott Laboratories (NYSE: ABT) easily surmounted Hump Day, rising by 3.4% and trouncing the S&P 500 index's gain as it did so. For the quarter, Abbott posted year-over-year sales growth of 23%, as its top line landed at $10.9 billion. Collectively, prognosticators tracking the healthcare company estimated that it would earn a bit more than $9.4 billion on the top line and post an adjusted net profit of $0.93.
Abbott Laboratories squashed third-quarter estimates Wednesday, helped by $1.9 billion in sales of Covid tests. ABT stock rose in response.
The S&P 500 and the Dow closed higher on Wednesday as investors eyed better than expected third-quarter earnings from U.S. companies. While the Nasdaq lagged as technology stocks took a breather, the Dow Jones Industrials Average surpassed its previous record reached in mid-August while the benchmark S&P 500 index came within five points of its early September record during the session. The S&P's healthcare index rallied for a second day in a row with help from Anthem and Abbott, which gained ...
The Dow briefly touched a record high and the S&P 500 traded close to its peak on Wednesday as investors eyed better than expected third-quarter earnings from U.S. companies. While the Nasdaq lagged as technology stocks took a breather, the S&P's utility sector was gaining sharply and the healthcare index rallied for a second day in a row after strong forecasts from Anthem and Abbott.
With the exception of any participants' questions asked during the question-and-answer session, the entire call, including the question-and-answer session, is material copyrighted by Abbott. It cannot be recorded or rebroadcast without Abbott's expressed written permission. With me today are Robert Ford, President and Chief Executive Officer; and Bob Funck, Executive Vice President, Finance and Chief Financial Officer.
The S&P 500 and the Dow inched closer to record highs on Wednesday after strong forecasts from healthcare companies Anthem and Abbott, while the Nasdaq lagged as technology stocks took a breather. The Dow Jones Industrials Average was just short of all-time highs reached in mid-August, while the benchmark S&P 500 index traded 0.2% below its early September record.